_:nea39ad98e41749adbca686d9bbeabad0xb0
<http://schema.org/description>
"\"We believe ropeginterferon alfa-2b could become an important new therapeutic tool and look forward to engaging with the regulators in our efforts to introduce this option to the underserved PV community in the United States.\""
<https://www.targetedonc.com/view/bla-for-ropeginterferon-alfa-2b-as-pv-treatment-accepted-by-the-fda>